Gordon W. Dewald

Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

Alan F. List, Gordon W. Dewald, John M. Bennett et al. · New England Journal of Medicine · 2006 · 1.3K citations

Medicine, Hematology, Pharmacology +17

Anthracycline Dose Intensification in Acute Myeloid Leukemia

Hugo F. Fernández, Zhuoxin Sun, Xiaopan Yao et al. · New England Journal of Medicine · 2009 · 907 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

Anthony V. Moorman, Christine J. Harrison, Georgina Buck et al. · Blood · 2006 · 748 citations · Full text

Life Sciences, Hematology, Oncology +14

Clinical and biologic implications of recurrent genomic aberrations in myeloma

Rafaël Fonseca, Emily Blood, Montserrat Rué et al. · Blood · 2003 · 661 citations

Medicine, Genetics, Oncology +14

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes

David P. Steensma, Gordon W. Dewald, Terra L. Lasho et al. · Blood · 2005 · 466 citations · Full text

Medicine, Genetics, Hematology +8